Neuroendocrine neoplasms (NENs) originate in the small intestine, pancreas, or large intestine. Hormonally active NENs secrete substances (serotonin, kinins, prostaglandins, and histamine) causing symptoms known as carcinoid syndrome. The symptoms occur if biogenic amines are secreted directly to the systemic circulation, most often with hepatic metastases. Hedinger syndrome is a heart disease characterised by plaque-like deposits of fibrous tissue, localised mainly on the tricuspid and pulmonary valves. The prognosis depends on the stage of the disease; according to European data, the five-year survival rate in those with liver metastases is 15% to 25%. The prognosis may improve if the primary tumour is removed. In patients with New York Heart Association (NYHA) class III/IV heart failure, the prognosis is unfavourable (median survival rate without cardiosurgical treatment is 11 months). We report a case of a 60-year-old patient with carcinoid disease involving grade 2 neuroendocrine tumours and disseminated disease, with liver metastases. His comorbidities were type 2 diabetes, hypertension, and hypercholesterolaemia. He was admitted to the Cardiology Department due to a month-long history of worsening exertional dyspnoea and fatigue (NYHA class III). He had had prior partial resection of the small intestine (2011), had finished a third course of peptide receptor radionuclide therapy with radioisotope-labelled somatostatin analogues (PRRT) two months before hospitalisation, and had been chronically treated with long-acting somatostatin analogues. On physical examination, blood pressure was 130/80 mmHg and heart rate was 90/min. Clinical pathological findings included muted breathing murmur over the right lung, hepatomegaly, and oedema in both legs. Blood tests showed features of cholestasis, mild increase in troponin T levels, and elevated B-type natriuretic peptide levels. Electrocardiography did not show any specific signs of right ventricular or atrial enlargement ( Fig. 
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